Doctors protest cost of Vertex cystic fibrosis drug as its scientists prepare to receive $3M 'Oscars of Science' award

By The Boston Globe
| April 12, 2024

Trikafta, which was approved in 2019 and works for about 90% of patients with the deadly genetic disease, had an annual list price of more than $326,000 in the United States at the end of last year.

Full story

#1

Physicians are in short supply. They are costly. Is the APP the answer to the CMO's workforce and budget challenges? ...

Amid the hype and promise, a growing tension is becoming clear: the reality of what AI can deliver versus what it can't. ...